Lack of Improvement of Oral Absorption of ME3277 by Prodrug Formation Is Ascribed to the Intestinal Efflux Mediated by Breast Cancer Resistant Protein (BCRP/ABCG2)
暂无分享,去创建一个
Yuichi Sugiyama | Chihiro Kondo | Hiroyuki Kusuhara | H. Kusuhara | Y. Sugiyama | J. Jonker | Chihiro Kondo | Hiroshi Suzuki | Michiko Suzuki | Hiroshi Suzuki | Reiko Onuki | Michiko Suzuki | Noriko Okudaira | Maho Kojima | Kazuya Ishiwata | Johan W. Jonker | N. Okudaira | R. Onuki | Maho Kojima | K. Ishiwata | H. Suzuki
[1] R. Loria,et al. Measurement of intestinal absorption in mice by a double-label radioisotope perfusion technic. , 1976, Laboratory animal science.
[2] P. Borst,et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[3] M Hosokawa,et al. The mammalian carboxylesterases: from molecules to functions. , 1998, Annual review of pharmacology and toxicology.
[4] Y Zhang,et al. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[5] D. Keppler,et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.
[6] Y. Sugiyama,et al. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine. , 2000, The Journal of pharmacology and experimental therapeutics.
[7] Y. Sugiyama,et al. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. , 2000, The Journal of pharmacology and experimental therapeutics.
[8] J. Schellens,et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. , 2000, Journal of the National Cancer Institute.
[9] Y. Sugiyama,et al. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] H. Melhus,et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. , 2001, The Journal of pharmacology and experimental therapeutics.
[11] H. Rosing,et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] L. Doyle,et al. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) , 2003, Oncogene.
[13] Jos H Beijnen,et al. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2003, Cancer research.
[14] Yuichi Sugiyama,et al. ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics* , 2003, Journal of Biological Chemistry.
[15] L. Benet,et al. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. , 2003, Current drug metabolism.
[16] Y. Sugiyama,et al. Quantitative Evaluation of the Function of Small Intestinal P-Glycoprotein: Comparative Studies Between in Situ and in Vitro , 2003, Pharmaceutical Research.
[17] H. Yuasa,et al. Influence of Anesthetic Regimens on Intestinal Absorption in Rats , 1993, Pharmaceutical Research.
[18] H. Kusuhara,et al. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[19] Y. Sugiyama,et al. Functional Analysis of SNPs Variants of BCRP/ABCG2 , 2004, Pharmaceutical Research.